Skip to main content
OpenTrials

Clinical trial condition

Neonatal Abstinence Syndrome

Explore clinical trials studying Neonatal Abstinence Syndrome. Study availability and eligibility vary by location and protocol.

55 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Neonatal Abstinence Syndrome trial results

Recruiting

Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome

NCT03533985

Conditions
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +4 more
Locations
  • Tulane University Hospital New Orleans, Louisiana, United States
  • Joseph M. Sanzari Children's Hospital Hackensack, New Jersey, United States
  • Northwell Health New Hyde Park, New York, United States
  • Mount Sinai West New York, United States
View Trial Details
Recruiting

An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)

NCT06576323

Conditions
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +6 more
Locations
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Penn Center for Women's Behavioral Wellness Philadelphia, Pennsylvania, United States
  • Pennsylvania Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Medication Treatment for Opioid Use Disorder in Expectant Mothers

NCT03918850

Conditions
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Drug Abuse, +12 more
Locations
  • Gateway Community Services Jacksonville, Florida, United States
  • Massachusetts General Hospital HOPE Clinic Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • University of New Mexico Milagro Clinic Albuquerque, New Mexico, United States
View Trial Details
Completed

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

NCT03911739

Conditions
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Drug Abuse, +12 more
Locations
  • Gateway Community Services Jacksonville, Florida, United States
  • Massachusetts General Hospital HOPE Clinic Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • CODA, Inc. Portland, Oregon, United States
View Trial Details
Completed

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

NCT03911466

Conditions
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Drug Abuse, +12 more
Locations
  • Gateway Community Services Jacksonville, Florida, United States
  • Massachusetts General Hospital HOPE Clinic Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • University of New Mexico Milagro Clinic Albuquerque, New Mexico, United States
View Trial Details

Related conditions